VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,612 | -30.2% | 15,296 | -21.9% | 0.05% | -24.2% |
| Q2 2023 | $589,526 | -85.5% | 19,579 | -84.4% | 0.07% | -85.6% |
| Q1 2023 | $4,056,492 | -16.6% | 125,394 | -26.1% | 0.46% | -16.3% |
| Q4 2022 | $4,862,304 | -99.9% | 169,655 | -3.2% | 0.55% | +12.3% |
| Q3 2022 | $4,228,577,000 | +5.0% | 175,314 | +19.2% | 0.49% | +13.3% |
| Q2 2022 | $4,026,976,000 | +60657.0% | 147,077 | -14.9% | 0.43% | -27.6% |
| Q1 2022 | $6,628,000 | +171.1% | 172,819 | +126.4% | 0.59% | +231.8% |
| Q4 2021 | $2,445,000 | -18.4% | 76,319 | -24.9% | 0.18% | -21.8% |
| Q3 2021 | $2,995,000 | +108.0% | 101,625 | +139.9% | 0.23% | +114.0% |
| Q2 2021 | $1,440,000 | +184.0% | 42,370 | +171.5% | 0.11% | +174.4% |
| Q1 2021 | $507,000 | – | 15,607 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |